z-logo
Premium
Influence of OCT 1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study
Author(s) -
Hahn David,
Emoto Chie,
Euteneuer Joshua C.,
Mizuno Tomoyuki,
Vinks Alexander A.,
Fukuda Tsuyoshi
Publication year - 2019
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.1249
Subject(s) - morphine , neonatal intensive care unit , pharmacogenetics , pharmacokinetics , physiologically based pharmacokinetic modelling , ontogeny , organic cation transport proteins , gestational age , genotype , pharmacology , transporter , critically ill , medicine , anesthesia , biology , pediatrics , gene , genetics , pregnancy
Morphine is commonly used for analgesia in the neonatal intensive care unit ( NICU ) despite having highly variable pharmacokinetics (PKs) between individual patients. The pharmacogenetic (PG) effect of variants at the loci of organic cation transporter 1 ( OCT 1 ) and UDP‐glucuronosyltransferase 2B7 ( UGT 2B7 ) on age‐dependent morphine clearance were evaluated in a cohort of critically ill neonatal patients using an opportunistic sampling design. Our primary results demonstrate the significant influence of OCT 1 genotype ( P  < 0.05) and gestational age ( P  ≤ 0.005) on morphine PKs. A physiologically based pharmacokinetic ( PBPK ) model for morphine that accounted for OCT 1 ontogeny and PG effect in post‐term neonates adequately described the clinically observed variability in morphine PKs. This study serves as a proof of concept for genotype‐dependent drug transporter ontogeny in neonates.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom